The Case for Greater Investment in VTE Research – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Ryan Coute et al, adding:
“National Institutes of Health Funding for Venous Thromboembolism Research.
Despite VTE causing approximately 100,000 annual US deaths, NIH funding per death remains critically disproportionate at 639 dollars for VTE compared to 2,765 dollars for heart disease and 2,724 dollars for stroke, highlighting a significant research investment gap that urgently needs to be addressed.”
Title: National Institutes of Health funding for venous thromboembolism research
Authors: Ryan A. Coute, Jake Toy, Kameshwari Soundararajan, Benjamin von Schweinitz, Patrick J. Siler, Ryan C. Godwin, Ryan L. Melvin
Read the Full Article on Journal of Thrombosis and Haemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF